Edding Genor Group Holdings Ltd

06998

Company Profile

  • Business description

    Edding Genor Group Holdings Ltd is an integrated specialty biopharmaceutical company, focusing on oncology, autoimmune diseases, cardiovascular diseases, respiratory diseases, and anti-infectives. Through the acquisition of branded drug assets from multinational pharmaceutical companies (MNCs) and licensing in development and commercialisation rights of patented drugs from international biopharmaceutical companies, it has established a portfolio of originator-branded and other drugs. The company has two reportable operating segments: Manufacturing and Distribution, which generates the maximum revenue, and Research and development. Geographically, it derives maximum revenue from the Chinese mainland, and the rest from the USA and other markets.

  • Contact

    No. 36 Doukou Road
    Room 406, Building 1
    Hengqin New Area
    Guangdong Province
    Zhuhai
    CHN

    https://www.eddingpharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    1,545

Stocks News & Analysis

stocks

Nvidia dominance continues

Our view on the latest earnings report.
stocks

Chart of the Week: Recent selloffs in this ASX sector opens doors to opportunity

Ongoing rate hikes have investors spooked.
stocks

ASX dividend champions: Stocks, ETFs and LICs

Mark and Shani run through lessons for ASX stocks, ETFs and LICs that have delivered over the past decade.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,883.209.00-0.10%
CAC 408,086.0031.42-0.39%
DAX 4024,606.77130.47-0.53%
Dow JONES (US)50,285.66276.310.55%
FTSE 10010,443.4711.130.11%
HKSE25,386.52264.60-1.03%
NASDAQ26,293.1022.740.09%
Nikkei 22562,790.561,106.421.79%
NZX 50 Index12,897.2119.140.15%
S&P 5007,445.7212.750.17%
S&P/ASX 2008,660.4011.70-0.13%
SSE Composite Index4,077.2884.91-2.04%

Market Movers